Travere Therapeutics (TVTX) Share-based Compensation (2012 - 2026)
Travere Therapeutics (TVTX) reported Share-based Compensation of $23.44 million for Q3 2026, up 108.1% from $11.26 million a year earlier and up 7.6% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Share-based Compensation (2012 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Travere Therapeutics' Share-based Compensation came in at $72.84 million, up 70.9% year-over-year; for FY2025, it came in at $44.87 million, up 21.6% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of 13.7% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $36.91 million in FY2024 (-16.6%), $44.25 million in FY2023 (+16.0%), $38.14 million in FY2022 (+29.0%) and $29.57 million in FY2021 (+25.2%).
- The Q3 2026 figure ranks as the highest quarterly Share-based Compensation in data going back to Q4 2012.
- Year over year, Share-based Compensation has now increased in each of the last eight quarters, with growth averaging 44.5% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q3 2026 (growth of 108.1%); the low point was Q3 2024 (a decline of 29.1%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $21.79 million (Q2 2026), $16.15 million (Q1 2026) and $11.46 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Travere Therapeutics | 4.97 Bn | 4.56 Bn | 221.70 Mn | 23.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 23.44 Mn |
| Jun 30, 2026 | 21.79 Mn |
| Mar 31, 2026 | 16.15 Mn |
| Dec 31, 2025 | 11.46 Mn |
| Sep 30, 2025 | 11.26 Mn |
| Jun 30, 2025 | 10.65 Mn |
| Mar 31, 2025 | 11.49 Mn |
| Dec 31, 2024 | 9.21 Mn |
| Sep 30, 2024 | 8.02 Mn |
| Jun 30, 2024 | 9.92 Mn |
| Mar 31, 2024 | 9.76 Mn |
| Dec 31, 2023 | 8.14 Mn |
| Sep 30, 2023 | 11.32 Mn |
| Jun 30, 2023 | 11.31 Mn |
| Mar 31, 2023 | 13.47 Mn |
| Dec 31, 2022 | 9.30 Mn |
| Sep 30, 2022 | 8.02 Mn |
| Jun 30, 2022 | 12.64 Mn |
| Mar 31, 2022 | 8.19 Mn |
| Dec 31, 2021 | 7.38 Mn |
API Access
Travere Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();